Fly News Breaks for March 9, 2015
SCOR, VNDA, LBIO, NVTA, INOV, IMNP, FNF, ATRC
Mar 9, 2015 | 09:59 EDT
Today's noteworthy initiations include: AtriCure (ATRC) initiated with a Buy at Needham... Fidelity National (FNF) initiated with a Buy at Monness Crespi... Immune Pharmaceuticals (IMNP) initiated with a Buy at Chardan... Inovalon (INOV) initiated with a Neutral at Piper Jaffray... Invitae (NVTA) initiated with an Overweight at JPMorgan... Lion Biotechnologies (LBIO) initiated with an Overweight at Piper Jaffray... Vanda (VNDA) initiated with a Buy at Jefferies... comScore (SCOR) initiated with a Buy at Sidoti.
News For ATRC;FNF;IMNP;INOV;NVTA;LBIO;VNDA;SCOR From the Last 2 Days
NVTA
Apr 24, 2024 | 21:24 EDT
Invitae (NVTA) announced that Labcorp (LH) has been selected as the winning bidder in the Company's auction in its sale process under Section 363 of the U.S. Bankruptcy Code. Labcorp will acquire substantially all of the Company's assets on a going concern basis for $239 million in cash consideration, plus other non-cash consideration. The hearing to approve the sale is currently scheduled for May 6, 2024. With Court approval, as well as customary regulatory approvals and closing conditions, Labcorp and Invitae anticipate completing the sale process in the third quarter of 2024.
ATRC
Apr 23, 2024 | 06:16 EDT
Oppenheimer analyst Suraj Kalia upgraded AtriCure to Outperform from Perform with a $32 price target.